Treanda and Pregnancy

There are potentially dangerous risks associated with using Treanda (bendamustine) during pregnancy. Women who are undergoing treatment with this drug should be aware that this pregnancy Category D medication was shown to cause miscarriages, birth defects, and other problems when given to pregnant animals. This medicine should only be given to a pregnant woman if the benefits to the mother outweigh the risks to the fetus.

Can Pregnant Women Receive Treanda?

Treanda® (bendamustine) is a prescription medication approved to treat people with certain blood and bone marrow cancers. It is considered a pregnancy Category D medication because it may cause harm to an unborn child if taken during pregnancy.

What Is Pregnancy Category D?

The U.S. Food and Drug Administration (FDA) uses a category system to classify the possible risks to a fetus when a specific medicine is taken during pregnancy. Pregnancy Category D is a classification given to medicines that have been shown to present a risk to the fetus in studies of pregnant women but may still offer benefits that outweigh the risks the drug presents. A pregnancy Category D medicine may still be given to a pregnant woman if her healthcare provider believes that the benefits to the woman outweigh the possible risks to her unborn child.
Treanda has not been adequately studied in pregnant women. When given to pregnant mice and rats, the drug caused a variety of problems, including miscarriages, low fetal body weights, and birth defects. Some of the observed birth defects included cleft palate and abnormalities of the head, tail, and spine.
Treanda should not be given to a pregnant woman unless her healthcare provider determines that the benefits to the mother outweigh the potential risks to the unborn child. This may be the case if safer medicines are not an option.
Women of childbearing potential should avoid getting pregnant by using an effective form of birth control during treatment and for at least three months after receiving the last dose. In addition, the manufacturer of Treanda recommends that men who receive this medication use a reliable form of contraception during treatment and for at least three months after treatment ends. Talk to your healthcare provider about the best birth control option for your particular situation.
Pregnancy and Pain

Treanda Medication Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2019 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.